title: Acquired Glanzmann thrombasthenia associated with Hodgkin lymphoma: rapid reversal of functional platelet defect with ABVD (adriamycin/bleomycin/vinblastine/dacarbazine) chemotherapy.
authors.affiliation: Internal Medicine, Boston University School of Medicine, Boston, MA.
authors.forename: Vinod
authors.initials: V
authors.lastname: Raman
authors.affiliation: Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA.
authors.forename: Karen
authors.initials: K
authors.lastname: Quillen
authors.affiliation: Hematology/Oncology, Boston University School of Medicine, Boston, MA. Electronic address: mark.sloan@bmc.org.
authors.forename: J Mark
authors.initials: JM
authors.lastname: Sloan
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D001792:Blood Platelets / Q000187:drug effects* / Q000502:physiology; D003606:Dacarbazine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006689:Hodgkin Disease / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D013915:Thrombasthenia / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome; D014747:Vinblastine / Q000008:administration & dosage
chemical_list: D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin
keywords: Auto-antibody; Bleeding; GpIIB/IIIa; Qualitative platelet dysfunction